Table 3.

Age-Adjusted Prevalence of Metabolic Syndrome with 95% Confidence Intervals by Ethnicity and Diagnostic Criteria

	NCEP-ATPIII		IDF		WHO
	Prevalence	95% CI	Prevalence	95% CI	Prevalence	95% CI
Total (n)	31.20% (453)	28.82%–33.58%	39.05% (567)	36.54%–41.56%	22.31% (324)	20.17%–24.45%
Caucasian	16.44%	11.39%–21.48%	20.50%	15.21%–25.78%	11.38%	6.80%–15.96%
Filipino	33.85%**	27.45%–40.26%	40.76%***	34.05%–47.47%	24.21%**	18.39%–30.03%
Part-Hawaiian	42.35%***	38.51%–46.18%	52.16%***	48.14%–56.18%	29.76%***	26.27%–33.24%
Japanese	26.29%	19.83%–32.74%	33.93%**	27.17%–40.69%	23.43%**	17.57%–29.29%
Mixed/other	27.24%*	21.80%–32.68%	36.34%**	30.64%–42.04%	17.56%	12.63%–22.50%

Bolded values indicate that prevalence values are significantly different from Caucasians for the given definition through Dunnett's post hoc test, ^*P < 0.05, ^**P < 0.01, and ^***P < 0.001.

CI, confidence interval; IDF, International Diabetes Federation; NCEP-ATPIII, National Cholesterol Education Program–Adult Treatment Panel III; WHO, World Health Organization.